Skip to Content

Clinical Trial Detail

CALGB 30607

Patient Information

Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer 

Study Number
CALGB 30607

Clinical Trial Categories

  • Lung Cancer - Metastatic

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Directions

Large Conference Room: Please enter the building through the door to the right of the main entrance…this door is a direct entrance to our meeting room. The Valet service is operating at our main entrance for our patients.

Also in this Section